PEACHTREE CORNERS, Ga., February 20, 2024 Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that a group of prominent cervical cancer doctors are in the final stages of completing the clinical data report that will be submitted for approval by the Chinese National Medical Products Administration (NMPA). The data quality assurance review team is being led by Dr. Sui Long, Director of the Gynecology Hospital at Fudan University and includes p
Guided Therapeutics, Inc. or the “Company” , the maker of LuViva, a rapid and painless cervical cancer detection system based on the Company’s patented biophotonic technology,. | May 1, 2023
Guided Therapeutics (GTHP) Enters Agreement to Begin Clinical Trial for US FDA Approval streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.